(Q47738927)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29050900%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

title

Bone and mineral disorders in chronic kidney disease: implications for cardiovascular health and ageing in the general population (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29050900%20AND%20SRC:MED&resulttype=core&format=json

chronic renal insufficiency

7 April 2020

main subject

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29050900%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Mario Cozzolino

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29050900%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

10

Mugurel Apetrii

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29050900%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

1

Adrian Covic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29050900%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

3

Ziad A Massy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29050900%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

author name string

Marc Vervloet

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29050900%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Pablo Ureña Torres

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29050900%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

David Goldsmith

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29050900%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Vincent Brandenburg

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29050900%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Pieter Evenepoel

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29050900%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Jordi Bover

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29050900%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

publication date

16 October 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29050900%20AND%20SRC:MED&resulttype=core&format=json

The Lancet: Diabetes & Endocrinology

7 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29050900%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29050900%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29050900%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

page(s)

319-331

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29050900%20AND%20SRC:MED&resulttype=core&format=json

Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis

7 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Klotho deficiency causes vascular calcification in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

1 reference

7 January 2021

Klotho gene deficiency causes salt-sensitive hypertension via monocyte chemotactic protein-1/CC chemokine receptor 2-mediated inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Changing bone patterns with progression of chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Small-molecule Klotho enhancers as novel treatment of neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Bone loss and the progression of abdominal aortic calcification over a 25 year period: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Vascular calcification: an update on mechanisms and challenges in treatment

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Decreased Bone Mineral Density Is an Independent Predictor for the Development of Atherosclerosis: A Systematic Review and Meta-Analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Arterial calcification: A new perspective?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

The relevance of mouse models for investigating age-related bone loss in humans

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Prevalence and Prognostic Implications of Coronary Artery Calcification in Low-Risk Women: A Meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Matrix metalloproteinases promote arterial remodeling in aging, hypertension, and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Cardiorespiratory fitness and coronary artery calcification in young adults: The CARDIA Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney Disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Bone quality--the material and structural basis of bone strength and fragility

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Trabecular bone score (TBS): Method and applications.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Incidence and risk factors for hip fractures in dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Temporal trends in fracture rates and postdischarge outcomes among hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Epidemiology and mortality of hip fracture among patients on dialysis: Taiwan National Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Increased risk of mortality associated with hip fracture in the dialysis population

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

High rates of death and hospitalization follow bone fracture among hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

The Aging Cardiovascular System: Understanding It at the Cellular and Clinical Levels

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Arterial calcification in chronic kidney disease: key roles for calcium and phosphate

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Subtotal nephrectomy alters tubular function: effect of phosphorus restriction

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Serum phosphate as a risk factor for cardiovascular events in people with and without chronic kidney disease: a large community based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

High dietary phosphorus density is a risk factor for incident chronic kidney disease development in diabetic subjects: a community-based prospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Relation between serum phosphate level and cardiovascular event rate in people with coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

24-hour urine phosphorus excretion and mortality and cardiovascular events

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

High dietary phosphorus intake is associated with all-cause mortality: results from NHANES III.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Is it possible to control hyperphosphataemia with diet, without inducing protein malnutrition?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Low socioeconomic status associates with higher serum phosphate irrespective of race

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Effect of behavioral stage-based nutrition education on management of osteodystrophy among hemodialysis patients, Lebanon

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Phosphorus homeostasis in normal health and in chronic kidney disease patients with special emphasis on dietary phosphorus intake

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Chronic kidney disease: a clinical model of premature aging

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Role of Klotho in aging, phosphate metabolism, and CKD.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

FGF23 induces left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Parathyroid-specific deletion of Klotho unravels a novel calcineurin-dependent FGF23 signaling pathway that regulates PTH secretion

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Phosphate balance in ESRD: diet, dialysis and binders against the low evident masked pool.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

The emerging role of Klotho in clinical nephrology

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study).

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Fibroblast growth factor-23 and incident coronary heart disease, heart failure, and cardiovascular mortality: the Atherosclerosis Risk in Communities study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Fibroblast growth factor-23 and cardiovascular disease in the general population: the Multi-Ethnic Study of Atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Fibroblast Growth Factor 23 and Cause-Specific Mortality in the General Population: The Northern Manhattan Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

The kidney is the principal organ mediating klotho effects

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Plasma Fibroblast Growth Factor 23: Clinical Correlates and Association With Cardiovascular Disease and Mortality in the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Fibroblast growth factor-23, cardiovascular prognosis, and benefit of angiotensin-converting enzyme inhibition in stable ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Relationship between circulating FGF23 and total body atherosclerosis in the community

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Initial FGF23-mediated signaling occurs in the distal convoluted tubule

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Gene profile analysis implicates Klotho as an important contributor to aging changes in brain white matter of the rhesus monkey.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Promoter methylation and age-related downregulation of Klotho in rhesus monkey

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Increased risk of hip fracture among patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Risk of hip fracture among dialysis and renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Relationship between moderate to severe kidney disease and hip fracture in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Increased risk of hip fracture among Japanese hemodialysis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Long-term fracture risk following renal transplantation: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

The mortality and direct medical costs of osteoporotic fractures among postmenopausal women in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Mortality after all major types of osteoporotic fracture in men and women: an observational study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Progression of vascular calcifications is associated with greater bone loss and increased bone fractures

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

1 reference

7 January 2021

When, how, and why a bone biopsy should be performed in patients with chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients--a single-center cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Adynamic bone disease: from bone to vessels in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Parathyroid hormone metabolism and signaling in health and chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Adynamic Bone Decreases Bone Toughness During Aging by Affecting Mineral and Matrix.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Evidence for abnormal calcium homeostasis in patients with adynamic bone disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Arterial calcifications and bone histomorphometry in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Mineral metabolism and cortical volumetric bone mineral density in childhood chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Bone Mineral Density Predicts Fractures in Chronic Kidney Disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Bone mineral density and fracture risk in older individuals with CKD.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Comparison of fracture risk prediction among individuals with reduced and normal kidney function.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Can DXA predict fractures in renal transplant patients?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

The clinical utility of FRAX to discriminate fracture status in men and women with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

FRAX predicts fracture risk in kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Bone mineral density and serum biochemical predictors of bone loss in patients with CKD on dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

The future burden of CKD in the United States: a simulation model for the CDC CKD Initiative

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Clinical practice. Calcium supplements and fracture prevention

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Calcium plus vitamin D supplementation and the risk of fractures

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Calcium intake and risk of fracture: systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Calcium intake and hip fracture risk in men and women: a meta-analysis of prospective cohort studies and randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

The effects of calcium supplementation on verified coronary heart disease hospitalization and death in postmenopausal women: a collaborative meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Cardiovascular complications of calcium supplementation in chronic kidney disease: are there arrhythmic risks?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Evolving importance of kidney disease: from subspecialty to global health burden

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Revisiting KDIGO clinical practice guideline on chronic kidney disease-mineral and bone disorder: a commentary from a Kidney Disease: Improving Global Outcomes controversies conference

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

The effect of raloxifene treatment in postmenopausal women with CKD.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Alendronate Treatment in Women With Normal to Severely Impaired Renal Function: An Analysis of the Fracture Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Effects of raloxifene on bone metabolism and serum lipids in postmenopausal women on chronic hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Effects of raloxifene on bone mineral metabolism in postmenopausal Japanese women on hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Bisphosphonate therapy in renal osteodystrophy--a review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Benefits and Harms of Osteoporosis Medications in Patients With Chronic Kidney Disease: A Systematic Review and Meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Bisphosphonate use in chronic kidney disease: association with adynamic bone disease in a bone histology series

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Long-term effects of bisphosphonate therapy: perforations, microcracks and mechanical properties.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

How to predict and treat increased fracture risk in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Effects of denosumab on fracture and bone mineral density by level of kidney function

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Renal effects of molecular targeted therapies in oncology: a review by the Cancer and the Kidney International Network (C-KIN).

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

A single-dose study of denosumab in patients with various degrees of renal impairment

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Treatment of Hemodialysis-Associated Adynamic Bone Disease with Teriparatide (PTH1-34): A Pilot Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Once-weekly teriparatide in hemodialysis patients with hypoparathyroidism and low bone mass: a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

The number, quality, and coverage of randomized controlled trials in nephrology.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

Fractures in Patients with CKD: Time for Action

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930310-8

7 January 2021

10.1016/S2213-8587(17)30310-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29050900%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

1 reference